{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T17:52:30Z","timestamp":1777053150691,"version":"3.51.4"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T00:00:00Z","timestamp":1715126400000},"content-version":"am","delay-in-days":312,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Preventive Medicine"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.ypmed.2023.107533","type":"journal-article","created":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T13:25:35Z","timestamp":1683120335000},"page":"107533","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Racial differences in COVID-19 severity associated with history of substance use disorders and overdose: Findings from multi-site electronic health records in New York City"],"prefix":"10.1016","volume":"172","author":[{"given":"Bennett","family":"Allen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cale","family":"Basaraba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Corbeil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bianca D.","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frances R.","family":"Levin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana M.","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharina","family":"Schultebraucks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brandy F.","family":"Henry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harold A.","family":"Pincus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Arout","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noa","family":"Krawczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.ypmed.2023.107533_bb0005","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.30479","article-title":"Racial and ethnic disparities in rates of COVID-19-associated hospitalization, intensive care unit admission, and in-hospital death in the United States from March 2020 to February 2021","volume":"4","author":"Acosta","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.ypmed.2023.107533_bb0010","series-title":"P S. Provisional drug overdose death counts. National Center for Health Statistics, Centers for Disease Control and Prevention","author":"Ahmad","year":"2023"},{"issue":"4","key":"10.1016\/j.ypmed.2023.107533_bb0015","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1001\/jamainternmed.2018.7700","article-title":"Racial differences in opioid overdose deaths in New York City, 2017","volume":"179","author":"Allen","year":"2019","journal-title":"JAMA Intern. Med."},{"issue":"3","key":"10.1016\/j.ypmed.2023.107533_bb0020","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1093\/pubmed\/fdaa241","article-title":"Association of substance use disorders and drug overdose with adverse COVID-19 outcomes in New York City: January-October 2020","volume":"43","author":"Allen","year":"2021","journal-title":"J. Public Health (Oxf)."},{"issue":"4","key":"10.1016\/j.ypmed.2023.107533_bb0025","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1177\/1524839919895507","article-title":"Health disparities and the heterogeneity of Blacks\/African Americans in the United States: why should we care?","volume":"21","author":"Amuta-Jimenez","year":"2020","journal-title":"Health Promot. Pract."},{"key":"10.1016\/j.ypmed.2023.107533_bb0030","series-title":"A. H. Unintentional Drug Poisoning (Overdose) Deaths in New York City in 2021. Vol. 133. New York City Department of Health and Mental Hygiene","author":"Askari","year":"2023"},{"issue":"9","key":"10.1016\/j.ypmed.2023.107533_bb0035","first-page":"1322","article-title":"Missing data in clinical research: a tutorial on multiple imputation","volume":"37","author":"Austin","year":"2021","journal-title":"Can. J. Cardiol."},{"issue":"4","key":"10.1016\/j.ypmed.2023.107533_bb0040","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0895-4356(00)00314-0","article-title":"Adjusting for multiple testing--when and how?","volume":"54","author":"Bender","year":"2001","journal-title":"J. Clin. Epidemiol."},{"issue":"1","key":"10.1016\/j.ypmed.2023.107533_bb0045","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J. R. Stat. Soc. Ser. B Methodol."},{"key":"10.1016\/j.ypmed.2023.107533_bb0050","doi-asserted-by":"crossref","first-page":"109297","DOI":"10.1016\/j.drugalcdep.2022.109297","article-title":"Risk factors for COVID-19 among persons with substance use disorder (PWSUD) with hospital visits - United States, April 2020-December 2020","volume":"232","author":"Board","year":"2022","journal-title":"Drug Alcohol Depend."},{"issue":"Suppl. 3","key":"10.1016\/j.ypmed.2023.107533_bb0055","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s11606-009-1069-7","article-title":"Heterogeneity in health insurance coverage among US Latino adults","volume":"24 Suppl 3","author":"Bustamante","year":"2009","journal-title":"J. Gen. Intern. Med."},{"issue":"3","key":"10.1016\/j.ypmed.2023.107533_bb0060","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.3418","article-title":"Forecasted and observed drug overdose deaths in the US during the COVID-19 pandemic in 2020","volume":"5","author":"Cartus","year":"2022","journal-title":"JAMA Netw. Open"},{"issue":"3","key":"10.1016\/j.ypmed.2023.107533_bb0065","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1056\/NEJMp2012910","article-title":"Racial health disparities and covid-19 - caution and context","volume":"383","author":"Chowkwanyun","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.ypmed.2023.107533_bb0070","doi-asserted-by":"crossref","DOI":"10.1001\/jamahealthforum.2021.0434","article-title":"Vaccine hesitancy is a scapegoat for structural racism","volume":"2","author":"Corbie-Smith","year":"2021","journal-title":"JAMA Health Forum."},{"key":"10.1016\/j.ypmed.2023.107533_bb0075","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2147\/CLEP.S129728","article-title":"Effect modification, interaction and mediation: an overview of theoretical insights for clinical investigators","volume":"9","author":"Corraini","year":"2017","journal-title":"Clin. Epidemiol."},{"issue":"1","key":"10.1016\/j.ypmed.2023.107533_bb0080","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s40615-020-00952-y","article-title":"The relationship between social determinants of health and racial disparities in COVID-19 mortality","volume":"9","author":"Dalsania","year":"2022","journal-title":"J. Racial Ethn. Health Disparities"},{"issue":"1","key":"10.1016\/j.ypmed.2023.107533_bb0085","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/10550887.2010.531672","article-title":"Effect of methadone maintenance treatment on heroin craving, a literature review","volume":"30","author":"Fareed","year":"2011","journal-title":"J. Addict. Dis."},{"issue":"11","key":"10.1016\/j.ypmed.2023.107533_bb0090","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.35967","article-title":"Variation in COVID-19 mortality in the US by race and ethnicity and educational attainment","volume":"4","author":"Feldman","year":"2021","journal-title":"JAMA Netw. Open"},{"issue":"7","key":"10.1016\/j.ypmed.2023.107533_bb0095","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1001\/jama.2021.13304","article-title":"Updated guidance on the reporting of race and ethnicity in medical and science journals","volume":"326","author":"Flanagin","year":"2021","journal-title":"Jama."},{"issue":"4","key":"10.1016\/j.ypmed.2023.107533_bb0100","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.3711","article-title":"Association of racial\/ethnic segregation with treatment capacity for opioid use disorder in counties in the United States","volume":"3","author":"Goedel","year":"2020","journal-title":"JAMA Netw. Open"},{"issue":"11","key":"10.1016\/j.ypmed.2023.107533_bb0105","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1503\/cmaj.110977","article-title":"Missing covariate data in clinical research: when and when not to use the missing-indicator method for analysis","volume":"184","author":"Groenwold","year":"2012","journal-title":"Cmaj."},{"issue":"3","key":"10.1016\/j.ypmed.2023.107533_bb0110","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s11414-013-9341-3","article-title":"Variation in use of buprenorphine and methadone treatment by racial, ethnic, and income characteristics of residential social areas in New York City","volume":"40","author":"Hansen","year":"2013","journal-title":"J. Behav. Health Serv. Res."},{"key":"10.1016\/j.ypmed.2023.107533_bb0115","doi-asserted-by":"crossref","first-page":"109383","DOI":"10.1016\/j.drugalcdep.2022.109383","article-title":"Substance use disorders and COVID-19: an analysis of nation-wide Veterans Health Administration electronic health records","volume":"234","author":"Hasin","year":"2022","journal-title":"Drug Alcohol Depend."},{"issue":"15","key":"10.1016\/j.ypmed.2023.107533_bb0120","doi-asserted-by":"crossref","first-page":"3973","DOI":"10.1007\/s11606-022-07610-5","article-title":"Disease-specific factors associated with readmissions or mortality after hospital discharge in COVID-19 patients: a retrospective cohort study","volume":"37","author":"Huang","year":"2022","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.ypmed.2023.107533_bb0125","author":"INSIGHT Clinical Research Network"},{"issue":"2","key":"10.1016\/j.ypmed.2023.107533_bb0130","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s10900-009-9209-x","article-title":"Factors associated with ethnic differences in health insurance coverage and type among Asian Americans","volume":"35","author":"Kao","year":"2010","journal-title":"J. Community Health"},{"key":"10.1016\/j.ypmed.2023.107533_bb0135","article-title":"COVID-19 complications among patients with opioid use disorder: a retrospective cohort study across five major NYC hospital systems","author":"Krawczyk","year":"2022","journal-title":"Addiction."},{"issue":"3","key":"10.1016\/j.ypmed.2023.107533_bb0140","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/PHH.0000000000001168","article-title":"Structural racism and the opioid overdose epidemic: the need for antiracist public health practice","volume":"26","author":"Kunins","year":"2020","journal-title":"J. Public Health Manag. Pract."},{"issue":"3","key":"10.1016\/j.ypmed.2023.107533_bb0145","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1007\/s11606-020-06353-5","article-title":"Derivation of a clinical risk score to predict 14-day occurrence of hypoxia, ICU admission, and death among patients with coronavirus disease 2019","volume":"36","author":"Levine","year":"2021","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.ypmed.2023.107533_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.101029","article-title":"Race, ethnicity, community-level socioeconomic factors, and risk of COVID-19 in the United States and the United Kingdom","volume":"38","author":"Lo","year":"2021","journal-title":"EClinicalMedicine."},{"issue":"11","key":"10.1016\/j.ypmed.2023.107533_bb0155","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.34147","article-title":"Disparities in COVID-19 outcomes by race, ethnicity, and socioeconomic status: a systematic-review and meta-analysis","volume":"4","author":"Magesh","year":"2021","journal-title":"JAMA Netw. Open"},{"issue":"1","key":"10.1016\/j.ypmed.2023.107533_bb0160","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/EDE.0000000000001432","article-title":"On the nature of informative presence bias in analyses of electronic health records","volume":"33","author":"McGee","year":"2022","journal-title":"Epidemiology."},{"issue":"3","key":"10.1016\/j.ypmed.2023.107533_bb0165","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/bioe.12992","article-title":"Moving beyond mistrust: centering institutional change by decentering the white analytical lens","volume":"36","author":"Newman","year":"2022","journal-title":"Bioethics."},{"key":"10.1016\/j.ypmed.2023.107533_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2020.108214","article-title":"Addressing racial & socioeconomic disparities in access to medications for opioid use disorder amid COVID-19","volume":"122","author":"Nguemeni Tiako","year":"2021","journal-title":"J. Subst. Abus. Treat."},{"issue":"12","key":"10.1016\/j.ypmed.2023.107533_bb0175","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.26881","article-title":"Assessment of racial\/ethnic disparities in hospitalization and mortality in patients with COVID-19 in New York City","volume":"3","author":"Ogedegbe","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.ypmed.2023.107533_bb0180","article-title":"Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study","volume":"369","author":"Petrilli","year":"2020","journal-title":"Bmj."},{"issue":"1","key":"10.1016\/j.ypmed.2023.107533_bb0185","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.amepre.2020.04.003","article-title":"Disparities in the population at risk of severe illness from COVID-19 by race\/ethnicity and income","volume":"59","author":"Raifman","year":"2020","journal-title":"Am. J. Prev. Med."},{"key":"10.1016\/j.ypmed.2023.107533_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108648","article-title":"Persons from racial and ethnic minority groups receiving medication for opioid use disorder experienced increased difficulty accessing harm reduction services during COVID-19","volume":"132","author":"Rosales","year":"2022","journal-title":"J. Subst. Abus. Treat."},{"issue":"5152","key":"10.1016\/j.ypmed.2023.107533_bb0195","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.15585\/mmwr.mm675152e1","article-title":"Drug and opioid-involved overdose deaths - United States, 2013-2017","volume":"67","author":"Scholl","year":"2018","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.ypmed.2023.107533_bb0200","article-title":"Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies","volume":"357","author":"Sordo","year":"2017","journal-title":"Bmj."},{"key":"10.1016\/j.ypmed.2023.107533_bb0205","author":"Substance Abuse and Mental Health Services Administration","year":"2021"},{"issue":"9","key":"10.1016\/j.ypmed.2023.107533_bb0210","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S2215-0366(21)00232-7","article-title":"Mental disorders and risk of COVID-19-related mortality, hospitalisation, and intensive care unit admission: a systematic review and meta-analysis","volume":"8","author":"Vai","year":"2021","journal-title":"Lancet Psychiatry"},{"issue":"21","key":"10.1016\/j.ypmed.2023.107533_bb0215","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1001\/jama.2020.7197","article-title":"Variation in COVID-19 hospitalizations and deaths across New York City Boroughs","volume":"323","author":"Wadhera","year":"2020","journal-title":"Jama."},{"issue":"1","key":"10.1016\/j.ypmed.2023.107533_bb0220","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41380-020-00880-7","article-title":"COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States","volume":"26","author":"Wang","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.ypmed.2023.107533_bb0225","article-title":"Association of COVID-19 with endocarditis in patients with cocaine or opioid use disorders in the US","author":"Wang","year":"2022","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.ypmed.2023.107533_bb0230","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/wps.20921","article-title":"Increased risk for COVID-19 breakthrough infection in fully vaccinated patients with substance use disorders in the United States between December 2020 and August 2021","volume":"21","author":"Wang","year":"2022","journal-title":"World Psychiatry"},{"issue":"6","key":"10.1016\/j.ypmed.2023.107533_bb0235","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.19651","article-title":"Comparison of substance use disorder diagnosis rates from electronic health record data with substance use disorder prevalence rates reported in surveys across sociodemographic groups in the veterans health administration","volume":"5","author":"Williams","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.ypmed.2023.107533_bb0240","author":"World Health Organization"},{"issue":"5","key":"10.1016\/j.ypmed.2023.107533_bb0245","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1111\/1475-6773.13975","article-title":"Using a structural vulnerability framework to understand the impact of COVID-19 on the lives of Medicaid beneficiaries receiving substance use treatment in New York City","volume":"57","author":"Zhen-Duan","year":"2022","journal-title":"Health Serv. Res."},{"key":"10.1016\/j.ypmed.2023.107533_bb0250","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.annepidem.2022.04.008","article-title":"Neighborhood disparities in COVID-19 outcomes in New York city over the first two waves of the outbreak","volume":"70","author":"Zhong","year":"2022","journal-title":"Ann. Epidemiol."}],"container-title":["Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743523001135?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743523001135?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T10:18:22Z","timestamp":1758795502000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091743523001135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":50,"alternative-id":["S0091743523001135"],"URL":"https:\/\/doi.org\/10.1016\/j.ypmed.2023.107533","relation":{},"ISSN":["0091-7435"],"issn-type":[{"value":"0091-7435","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Racial differences in COVID-19 severity associated with history of substance use disorders and overdose: Findings from multi-site electronic health records in New York City","name":"articletitle","label":"Article Title"},{"value":"Preventive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ypmed.2023.107533","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107533"}}